Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Equity Average: 2020-2021

  • Bright Minds Biosciences' Equity Average was N/A to $21.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $21.8 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2020, which is N/A change from last year.
  • Bright Minds Biosciences' Equity Average amounted to $21.8 million in Q2 2021, which was up 64.81% from $13.2 million recorded in Q1 2021.
  • In the past 5 years, Bright Minds Biosciences' Equity Average ranged from a high of $21.8 million in Q2 2021 and a low of $3.3 million during Q3 2020.
  • Its 2-year average for Equity Average is $10.6 million, with a median of $8.7 million in 2020.